A prospective observational study for patients with community-acquired, health-care-associated, hospital-acquired, and ventilator-associated pneumonia in a Japanese University Hospital
Not Applicable
Recruiting
- Conditions
- community-acquired (CAP), health-care-associated (HCAP), hospital-acquired (HAP), and ventilator-associated pneumonia (VAP)
- Registration Number
- JPRN-UMIN000007090
- Lead Sponsor
- Department of Respiratory Medicine, Nagoya University Graduate School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 1420
Inclusion Criteria
Not provided
Exclusion Criteria
1) Patients who do not receive initial empirical antibiotic treatment 2) Patients with obstructive pneumonia 3) Pneumonia occurred in other hospitals and patients who were transferred from their hospitals with a tendency to improve 4) Patients whose pneumonia recurred within 3 days after the last day of antibiotic treatment of a preceding pneumonia episode 5) Patients who receive the treatment in an outpatient clinic 6) Patients who are less than 20 years old
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1) 30-day mortality and in-hospital mortality 2) Identified pathogens and drug resistance 3) Early and late treatment failure 4) Appropriateness of antibiotic treatment 5) Outcomes and their clinical prediction rules for patients with each category of pneumonia (CAP, HCAP, HAP, and VAP) 6) Adherence to practice guidelines in initial empirical antibiotic treatment for patients with each category of pneumonia (CAP, HCAP, HAP, and VAP) 7) molecular genetic characteristics of identified pathogens
- Secondary Outcome Measures
Name Time Method